GKB Ophthalmics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from GKB Ophthalmics Ltd. on BSE

Search Inside the pdf :

GKB Ophthalmics Ltd.

02 Jun 2025

74.98

-0.36%

Company Update

GKB Ophthalmics Ltd - 533212 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find attached copies of newspaper cuttings of the extract of statement of audited Standalone and Consolidated Financial Results for the year ended March 31, 2025, published in The Financial Express (Mumbai Edition) and on Pudhari(Marathi) Dated June 01, 2025.

pdf

GKB Ophthalmics Ltd.

30 May 2025

74.98

-0.36%

Result

GKB Ophthalmics Ltd - 533212 - GKB- Audited Standalone And Consolidated Financial Results For The Quarter …

BSE India

Please find enclosed the Audited Standalone and Consolidated Results for the quarter and year ended March 31, 2025.

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	31.36	26.29	22.06	19.3%	42.2%
Operating Profit Qtr	-2.85	-0.91	0.01	-213.2%	-28600.0%
Net Profit Qtr	-3.55	-2.03	-0.91	-74.9%	-290.1%
Earning Per Share Adjusted latest Qtr	-7.03	-4.03	-1.81	-74.4%	-288.4%

* Consolidated data

Detailed Results

GKB Ophthalmics Ltd.

30 May 2025

74.98

-0.36%

Company Update

GKB Ophthalmics Ltd - 533212 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Pursuant to circular no. CIR/CFD/CMDI/27/2019 dated February 08, 2019, issued by the securities and Exchange Board of India, for the purpose of compliance with Regulation 24A of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, enclosed please find the Annual Secretarial Complaince Report for the year ended March 31, 2025, issued by Ms. Girija Nagvekar, Practicing Company Secretary and Secretarial Auditor of the Company.

pdf

GKB Ophthalmics Ltd.

30 May 2025

74.98

-0.36%

Board Meeting

GKB Ophthalmics Ltd - 533212 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

The meeting of the Board of Directors was held on May 30, 2025 which inter-alia approved and took on record the Audited Standalone and Consolidated Financials Results of the Company for the quarter and year ended March 31, 2025. Enclosed please find the Standalone and Consolidated financial results together with the Auditors'' Report. The Board of Directors'' Meeting started at 5:15 P.M. and ended at 6.00 P.M. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

14 May 2025

74.98

-0.36%

Board Meeting

GKB Ophthalmics Ltd - 533212 - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated …

BSE India

GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the company for the quarter and year ended March 31, 2025. The Notice can be accessed at the Company''s Website at www.gkb.net Further,notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI (Prohibition of Insider Trading) Regulation, 2015, had been closed from April 01, 2025, will now re-open after the completion of 48 hours from the date of submission of financials results to the Stock Exchange. This communication has been sent to all the Directors and all the designated employees of the Company.

pdf

GKB Ophthalmics Ltd.

21 Apr 2025

74.98

-0.36%

Company Update

GKB Ophthalmics Ltd - 533212 - Intimation Of Change In Contact Details Of Registrar And Share …

BSE India

We wish to inform that MUFG Intime India Private Limited (''MUFG'') has intimated the company about the change in email address and website as under: 1. Email address: rnt.helpdesk@in.mpms.mufg.com 2. Website: www.in.mpms.mufg.com Further , the RTA has also informed that all the shareholder queries or service requests in electronic mode are to be raised only through their website at https://web.in.mpms.mufg.com/helpdesk/Service_Request.html. We request you to take the above information on record.

pdf

GKB Ophthalmics Ltd.

10 Apr 2025

74.98

-0.36%

Company Update

GKB Ophthalmics Ltd - 533212 - Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26, 2018.

BSE India

Pursuant to Circular No. SEBI/HO/DDHS/CIR/P/2018/144, dated November 26, 1018, issued by the Securities Exchange Board of India, we hereby confirm that GKB Ophthalmics Limited is not a "Large Corporate", as defined in the said Circular and hence, the said Circular is not applicable to us. Kindly take the above information on record.

pdf

GKB Ophthalmics Ltd.

09 Apr 2025

74.98

-0.36%

Company Update

GKB Ophthalmics Ltd - 533212 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations , 2015 , we hereby inform that CRISIL Rating Limited ("CRISIL Ratings") has reaffirmed the credit ratings for the bank -based facilities of the Company , vide their letter dated April 09, 2025. A copy of the Rating Rationale issued by CRISIL is enclosed. We request you to take the above information on record.

pdf

GKB Ophthalmics Ltd.

08 Apr 2025

74.98

-0.36%

Company Update

GKB Ophthalmics Ltd - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find herewith Certificate under Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018 , for the quarter ended March 31, 2025 Kindly acknowledge the receipt of the same.

pdf

GKB Ophthalmics Ltd.

02 Apr 2025

74.98

-0.36%

Company Update

GKB Ophthalmics Ltd - 533212 - Disclosure Under Regulations 31 (4) Of SEBI (Substantial Acquisition Of …

BSE India

Please find enclosed herewith the disclosure under Regulation 31 (4) of Securities and exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulation 2011 for the financial year ended on March 31, 2025, received from Mr. Krishna Gopal Gupta (K.G. Gupta), Promoter of the Company on behalf of Promoter and Promoter group of the Company. We request you to please take the above information on record.

pdf

Is GKB Ophthalmics Ltd. worth buying?

12 Votes:

Buy 66.67%

Sell 33.33%